Celldex Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €6.05M +2.0% -€136.01M +11.6% -2,248.8% -1.9 pp -€134.28M +47.8% -2,220.2% -6.9 pp
    €5.93M +192.0% -€121.85M +15.2% -2,054.8% +32 pp -€90.87M +3.5% -1,532.4% +28 pp
    €2.03M -49.3% -€105.78M +74.1% -5,209.3% -37 pp -€87.80M +70.8% -4,323.5% -30 pp
    €4.01M -37.3% -€60.75M +18.0% -1,516.0% -7.1 pp -€51.40M +53.6% -1,282.7% -7.6 pp
    €6.39M +107.6% -€51.50M +18.7% -805.9% +6.0 pp -€33.47M -15.0% -523.8% +7.5 pp
    €3.08M -62.5% -€43.40M -66.7% -1,409.8% +1.8 pp -€39.36M -38.6% -1,278.6% -5.0 pp
    €8.22M -25.2% -€130.25M +62.5% -1,585.1% -8.6 pp -€64.12M -24.2% -780.3% -0.10 pp
    €10.98M +87.8% -€80.15M -27.6% -730.1% +12 pp -€84.56M -11.0% -770.2% +8.6 pp
    €5.85M +23.8% -€110.73M +1.0% -1,894.0% +4.3 pp -€95.02M +17.3% -1,625.2% +0.90 pp
    €4.72M +52.8% -€109.59M +7.7% -2,321.1% +9.7 pp -€81.00M -5.6% -1,715.5% +11 pp
    €3.09M -12.8% -€101.73M +44.8% -3,292.8% -13 pp -€85.82M +57.0% -2,777.7% -12 pp
    €3.54M -63.3% -€70.26M +37.9% -1,983.7% -15 pp -€54.67M +28.2% -1,543.4% -11 pp
    €9.65M +20.9% -€50.94M +32.0% -527.8% -0.44 pp -€42.63M +40.8% -441.7% -0.62 pp
    €7.98M -80.2% -€38.60M +1,668.6% -483.5% -4.8 pp -€30.28M +24.3% -379.4% -3.2 pp
    €40.31M +208.3% -€2.18M -93.1% -5.4% +2.4 pp -€24.36M -3.6% -60.4% +1.3 pp
    €13.08M +103.6% -€31.47M -23.1% -240.6% +4.0 pp -€25.28M -249.8% -193.3% -4.6 pp
    €6.42M +46.1% -€40.92M +119.5% -637.1% -2.1 pp €16.87M -236.7% 262.7% +5.4 pp
    €4.40M +3.5% -€18.64M +6.2% -424.0% -0.11 pp -€12.34M -139.4% -280.8% -10 pp
    €4.25M +59.7% -€17.55M +12.6% -413.2% +1.7 pp €31.30M -703.7% 736.7% +9.3 pp
    €2.66M -55.0% -€15.59M +37.1% -586.0% -3.9 pp -€5.18M -41.9% -194.8% -0.44 pp
    €5.91M +48.0% -€11.38M +4.2% -192.5% +0.81 pp -€8.92M -10.2% -151.0% +0.98 pp
    €3.99M -30.9% -€10.92M -8.4% -273.5% -0.67 pp -€9.93M -28.4% -248.9% -0.089 pp
    €5.78M +100.4% -€11.91M -39.2% -206.3% +4.7 pp -€13.86M -20.4% -240.0% +3.6 pp
    €2.88M +338.4% -€19.60M +3.5% -680.0% +22 pp -€17.42M +375.2% -604.3% -0.47 pp
    €657.53K -48.6% -€18.93M +94.3% -2,879.3% -21 pp -€3.67M -45.8% -557.5% -0.28 pp
    €1.28M -32.6% -€9.74M -78.2% -762.3% +16 pp -€6.76M -8.7% -529.2% -1.4 pp
    €1.90M +83.3% -€44.63M +295.4% -2,354.5% -13 pp -€7.41M +13.2% -390.9% +2.4 pp
    €1.03M +9.1% -€11.29M +21.3% -1,091.7% -1.1 pp -€6.55M -16.5% -633.3% +1.9 pp
    €947.70K -72.5% -€9.30M +30.1% -981.8% -7.7 pp -€7.84M +24.7% -827.3% -6.4 pp
    €3.45M -42.9% -€7.15M -28.4% -207.5% -0.42 pp -€6.29M -12.0% -182.5% -0.64 pp
    €6.03M -22.2% -€9.99M +48.7% -165.7% -0.79 pp -€7.15M +66.0% -118.6% -0.63 pp
    €7.75M -11.8% -€6.72M +129.4% -86.7% -0.53 pp -€4.31M +92.3% -55.6% -0.30 pp
    €8.79M -6.4% -€2.93M +240.0% -33.3% -0.24 pp -€2.24M -∞% -25.5% -0.25 pp
    €9.39M +39.7% -€861.55K -9.1% -9.2% +0.049 pp €0.00 +NaN% 0.0% +0.0 pp
    €6.72M +69.6% -€947.70K -8.3% -14.1% +0.12 pp €0.00 +NaN% 0.0% +0.0 pp
    €3.96M +109.1% -€1.03M +50.0% -26.1% +0.10 pp €0.00 -100.0% 0.0% -5.6 pp
    €1.90M -€689.24K -36.4% €10.60M 559.1%

    Notifications